Dermata Therapeutics, INC Form 4 insider transactions

NASDAQ
A Dermata Therapeutics director, Steven J Mento, acquired 5,000 stock options on January 13, 2025.
NASDAQ
Kathleen D. Scott, a director at Dermata Therapeutics, acquired 5,000 stock options on January 13, 2025.